CC
TPTX

Carlson Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Carlson Capital’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-415,000
Closed -$31.2M – 155
2022
Q2 		$31.2M Buy
+415,000
New +$18.4M 2.15% 12

Carlson Capital's TPTX Position: Q3 2022 in Review

Carlson Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 415,000 shares — an estimated $31.2M sold.

Carlson Capital first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $31.2M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Carlson Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Carlson Capital sold 415,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $31.2M.
  • Carlson Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Carlson Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $31.2M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Carlson Capital's 13F filing for Q3 2022, filed 14 Nov 2022.